HRT Financial’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.94M Buy
1,726,196
+1,029,519
+148% +$3.27M 0.01% 1151
2025
Q4
$2.79M Buy
696,677
+294,626
+73% +$1.64M 0.01% 1090
2025
Q3
$3.4M Buy
+402,051
New +$3.9M 0.01% 861
2025
Q1
Sell
-66,548
Closed -$748K 2737
2024
Q4
$748K Sell
66,548
-24,255
-27% -$426K ﹤0.01% 1239
2024
Q3
$2.57M Buy
90,803
+29,625
+48% +$764K 0.01% 779
2024
Q2
$1.17M Buy
61,178
+36,073
+144% +$921K 0.01% 953
2024
Q1
$823K Buy
+25,105
New +$801K 0.01% 979
2022
Q4
Sell
-92,664
Closed -$3.33M 2651
2022
Q3
$3.33M Buy
+92,664
New +$3.26M 0.04% 413
2019
Q4
Sell
-13,424
Closed -$96K 1288
2019
Q3
$96K Buy
+13,424
New +$96.3K ﹤0.01% 1250

Other funds holding EVH

HRT Financial's EVH Position: Q1 2026 in Review

HRT Financial increased its Evolent Health (EVH) stake by 148% in Q1 2026, buying an estimated $3.27M and bringing the position to 1,726,196 shares worth $3.94M. The position accounts for 0.01% of the portfolio, ranked #1151.

HRT Financial first reported a position in EVH in Q3 2019 and has held it in 9 quarters since. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • HRT Financial held 1,726,196 shares of Evolent Health worth $3.94M as of Q1 2026.
  • HRT Financial bought 1,029,519 Evolent Health shares in Q1 2026, an estimated $3.27M.
  • Evolent Health made up 0.01% of HRT Financial's portfolio in Q1 2026, its #1151 holding.
  • HRT Financial first reported a position in Evolent Health in Q3 2019 and has held it in 9 quarters since.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.